Efficacy of FGFR Inhibitors and Combination Therapies for Acquired Resistance in FGFR2-Fusion Cholangiocarcinoma
Melanie A. Krook(The Ohio State University), Sameek Roychowdhury(The Ohio State University Wexner Medical Center), Michele R. Wing(The Ohio State University), Hannah Barker(The Ohio State University), Julie W. Reeser(The Ohio State University), Jharna Miya(The Ohio State University), Dorrelyn M. Martin(The Ohio State University), Alexandria Lenyo(The Ohio State University), Kristen K. Ciombor(The Ohio State University), Aharon G. Freud, Mikayla Dantuono(The Ohio State University), Max Wilberding(The Ohio State University), Kelly M. Bailey(University of Pittsburgh), Amy Smith(Nationwide Children's Hospital), Thuy Dao(The Ohio State University), John L. Hays(The Ohio State University), Hui‐Zi Chen(The Ohio State University), Eric Samorodnitsky(The Ohio State University)
Cited by 138
Related Papers
Landscape of Microsatellite Instability Across 39 Cancer Types
|JCO Precision Oncology|2017|1.5k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
|Nature Genetics|2013|1.2k